Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo

A
ACE inhibitor 13.2 Antipsychotics
acetylcholinesterase inhibitor 13.4 Anxiolytics and Sedative-Hypnotics
Acne vulgaris 40.2 Acne Drugs
Acnecycline 40.2 Acne Drugs
acquired immunodeficiency syndrome (AIDS) 7.3 Introduction to HIV, AIDS, and Antiretrovirals
Activated clotting time (ACT) 20.2 Anticoagulants
active transport 4.1 What Is Homeostasis?
acute angle-closure (narrow-angle) glaucoma 38.4 Antiglaucoma Drugs
acute kidney injury (AKI) 34.1 Introduction to Diuretics
Adapalene 40.2 Acne Drugs
adaptive immune system 6.1 Introduction to Immunity
adenosine 5-triphosphate (ATP) 4.3 Maintaining Homeostasis
Adipex-P 32.2 Anorexiants
Adjuvant therapy 8.2 Chemotherapeutic Drugs
adrenal insufficiency 25.2 Corticosteroids
adrenergic agonist 22.2 Cardiac Emergency Drugs
adverse drug reaction 3.2 Drug Errors and Prevention
Agency for Healthcare Research and Quality 3.3 Documentation and Informatics
Alka-Seltzer 31.1 Antacids
Alkyl Sulfonates 8.2 Chemotherapeutic Drugs
Alkylating agents 8.2 Chemotherapeutic Drugs
Alkylating-Like Drugs 8.2 Chemotherapeutic Drugs
Alpha- and beta-adrenergic agonists 25.1 Adrenergics and Anticholinergics
alpha-1 receptor agonist 22.3 Shock Drugs
alpha-2 adrenergic agonist 13.4 Anxiolytics and Sedative-Hypnotics
Alpha-glucosidase inhibitors 28.3 Oral Antidiabetic Drugs
Alteplase 20.4 Thrombolytics
Aluminum hydroxide 31.1 Antacids
Alzheimer’s disease (AD) 10.3 Introduction to Alzheimer’s Disease
American Academy of Child and Adolescent Psychiatry 13.2 Antipsychotics
American Academy of Ophthalmology 38.1 Introduction to the Eyes
American College of Obstetricians and Gynecologists 36.2 Hormonal, Contraception, and Infertility Drugs
American Geriatrics Society Beers Criteria 11.2 Anti-Parkinsonian Drugs
American Nurses Association (ANA) 3.2 Drug Errors and Prevention
American Psychiatric Association 13.1 Antidepressants
Amphetamine and dextroamphetamine 13.5 CNS Stimulants and Nonstimulants
Amphojel 31.1 Antacids
ANA Code of Ethics 3.2 Drug Errors and Prevention
Anaphylactic shock 22.3 Shock Drugs
Anastrozole 8.3 Hormonal Therapy
angiotensin receptor/neprilysin inhibitors (ARNIs) 19.2 Drugs Affecting the Renin-Angiotensin-Aldosterone System
Anorexiants 32.2 Anorexiants
Anthracyclines/Antitumor Antibiotics 8.2 Chemotherapeutic Drugs
Anti-factor Xa level (Anti-Xa) 20.2 Anticoagulants
anti-inflammatory 13.2 Antipsychotics
Antianginal drugs Introduction
Antibody mediated/humoral immunity 6.1 Introduction to Immunity
anticholinergic effects 30.2 Antidiarrheals
Anticoagulant Reversal Agents 20.2 Anticoagulants
Anticoagulants 20.2 Anticoagulants
antidepressant responses in populations of color 13.1 Antidepressants
Antiestrogens 8.3 Hormonal Therapy
Antigen-antibody interactions 6.1 Introduction to Immunity
Antihypertensive drugs Introduction
antiseizure medications 13.3 Mood Stabilizers
Antitussives 24.2 Antitussives
Antivert 30.1 Antiemetics
Apomorphine hydrochloride 11.2 Anti-Parkinsonian Drugs
apothecary system 2.4 Dosage Calculations
Aprepitant 30.1 Antiemetics
Argatroban 20.2 Anticoagulants
Aromatase Inhibitors 8.3 Hormonal Therapy
asociality 13.2 Antipsychotics
Atralin 40.2 Acne Drugs
atrial fibrillation with rapid ventricular response 17.1 Introduction to Dysrhythmias, 22.2 Cardiac Emergency Drugs
Attention deficit hyperactivity disorder 13.5 CNS Stimulants and Nonstimulants
atypical antipsychotics 13.2 Antipsychotics
Azelaic acid 40.2 Acne Drugs
B
basal metabolic rate (BMR) 32.1 Introduction to Weight Management
basic formula method 2.4 Dosage Calculations
Beclomethasone 25.2 Corticosteroids
benign Introduction
Benign paroxysmal positional vertigo (BPPV) 39.1 Introduction to the Ears
benign prostatic hyperplasia (BPH) 35.5 Phosphodiesterase 5 Inhibitors
benzodiazepine sedative-hypnotic 13.2 Antipsychotics
Benzonatate 24.2 Antitussives
benzothiadiazine 28.3 Oral Antidiabetic Drugs
Benzoyl peroxide 40.2 Acne Drugs
Benzphetamine 32.2 Anorexiants
Benztropine mesylate 11.2 Anti-Parkinsonian Drugs
beta-1 adrenergic agonist 22.2 Cardiac Emergency Drugs
beta-1 receptor agonist 22.3 Shock Drugs
beta-2 adrenergic agonist 25.1 Adrenergics and Anticholinergics
Betaxolol hydrochloride 38.4 Antiglaucoma Drugs
Bethanechol chloride 35.4 Urinary Stimulants
Bimatoprost 0.01% and 0.03% solution 38.4 Antiglaucoma Drugs
biologic psoriatic drugs 40.3 Psoriatic Drugs
Biologic Response Modifiers 8.4 Biologic Response Modifiers
Biologic therapy 8.2 Chemotherapeutic Drugs
bipolar disorder 13.1 Antidepressants
Bismuth subsalicylate 30.2 Antidiarrheals
Bivalirudin 20.2 Anticoagulants
bladder pain syndrome 35.3 Urinary Analgesics
blood dyscrasias 35.1 Urinary Anti-infectives
Blood products 5.1 Fluid Volume
board of nursing (BON) 3.1 Legal Considerations
body surface area 2.4 Dosage Calculations
body surface area (BSA) method 2.4 Dosage Calculations
body weight method 2.4 Dosage Calculations
Bowman’s capsule hydrostatic pressure 33.1 Introduction to the Renal System
Brinzolamide 1% solution 38.4 Antiglaucoma Drugs
Buprenorphine-naltrexone 15.2 Opioid Use Disorder Drugs
C
Calcipotriene 40.3 Psoriatic Drugs
Calcitonin gene related peptide (CGRP) receptor antagonists 12.2 Migraine Headaches and Migraine Headache Drugs
Calcium (Ca) 5.2 Electrolytes
Calcium polycarbophil 30.3 Laxatives and Stool Softeners
Canada’s drug laws 1.2 Drug Sources, Forms, and Names
Canadian Food and Drugs Act 1.2 Drug Sources, Forms, and Names
candidiasis 25.2 Corticosteroids
Cangrelor 20.3 Antiplatelets
Cannabinoids 30.1 Antiemetics
Carbidopa/levodopa extended release 11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa immediate-release tablet 11.2 Anti-Parkinsonian Drugs
Carbidopa/levodopa oral disintegrating tablet 11.2 Anti-Parkinsonian Drugs
Cardiac emergencies Introduction
cardiotoxicity 13.1 Antidepressants
Cardiovascular diseases Introduction
Cariprazine 13.2 Antipsychotics
Carteolol hydrochloride 38.4 Antiglaucoma Drugs
Catecholomethyltransferase (COMT) Inhibitors 11.2 Anti-Parkinsonian Drugs
Cathflo Activase 20.4 Thrombolytics
cell-cycle nonspecific (CCNS) 8.2 Chemotherapeutic Drugs
cell-cycle specific agents (CCS) 8.2 Chemotherapeutic Drugs
Cell-mediated immunity 6.1 Introduction to Immunity
Center for Drug Evaluation and Research (CDER) 1.2 Drug Sources, Forms, and Names
Chemokine Coreceptor (CCR5) Antagonists 7.3 Introduction to HIV, AIDS, and Antiretrovirals
chemoreceptor trigger zone (CTZ) 30.1 Antiemetics
chemotherapy administration 8.2 Chemotherapeutic Drugs
Chloride (Cl) 5.2 Electrolytes
chlorpropamide 13.2 Antipsychotics
cholesterol absorption inhibitors 21.4 Cholesterol Absorption Inhibitors
Cholinergic agonists 10.2 Cholinergic Drugs
cholinergic blockers 11.2 Anti-Parkinsonian Drugs
cholinergic receptors Introduction
Chronic obstructive pulmonary disease (COPD) 23.2 Introduction to the Lower Respiratory System, Introduction
Cinvanti 30.1 Antiemetics
Ciprofloxacin 0.2%
and hydrocortisone 1%
39.2 Otic Anti-inflammatories and Anti-infectives
Ciprofloxacin 0.3%
and dexamethasone 0.1%
39.2 Otic Anti-inflammatories and Anti-infectives
Ciprofloxacin
hydrochloride 0.3%
38.2 Ocular Anti-inflammatories and Anti-infectives
Class I: Sodium channel blockers 17.1 Introduction to Dysrhythmias
class Ia antiarrhythmic 22.2 Cardiac Emergency Drugs
Class II: Beta-adrenergic blockers 17.1 Introduction to Dysrhythmias
class III antiarrhythmic 22.2 Cardiac Emergency Drugs
Class III: Potassium channel blockers 17.1 Introduction to Dysrhythmias
class IV antiarrhythmic 22.2 Cardiac Emergency Drugs
Class IV: Calcium channel blocker 17.1 Introduction to Dysrhythmias
class V antidysrhythmic 22.2 Cardiac Emergency Drugs
Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar) 15.3 Alcohol Use Disorder Drugs
Clopidogrel 20.3 Antiplatelets
Closed-angle glaucoma 38.1 Introduction to the Eyes
Coal tar lotion 40.3 Psoriatic Drugs
Coal tar shampoo 40.3 Psoriatic Drugs
Colony Stimulating Factors 8.2 Chemotherapeutic Drugs
Combined oral contraceptives (COCs) 36.2 Hormonal, Contraception, and Infertility Drugs
Comorbidity Tests 28.1 Introduction to Diabetes
Compazine 30.1 Antiemetics
complementary and alternative medicine (CAM) 1.2 Drug Sources, Forms, and Names
complete blood count (CBC) Introduction
Computed tomography (CT) scan 12.1 Epilepsy and Anticonvulsant Drugs
computerized prescriber order entry (CPOE) 3.3 Documentation and Informatics
confidentiality 3.1 Legal Considerations
Conjugated estrogens 37.2 Feminizing Hormonal Therapy
Conjunctival hyperemia 38.4 Antiglaucoma Drugs
controlled substances 14.3 Opioid Agonists and Antagonists
Controlled Substances Act 1.3 Drug Classifications and Prototypes
cultural considerations 1.4 Special Considerations
customary system 2.4 Dosage Calculations
cyclooxygenase 14.1 Introduction to Pain
Cyclophosphamide 8.2 Chemotherapeutic Drugs
cytochrome P-450 (CYP) deficiencies 32.1 Introduction to Weight Management
cytochrome P450 enzyme system 13.1 Antidepressants
D
Dabigatran 20.2 Anticoagulants
Dalteparin 20.2 Anticoagulants
Depakote ER 13.3 Mood Stabilizers
depot injections 13.2 Antipsychotics
Desiccated thyroid extract 27.2 Thyroid and Antithyroid Drugs
Dextromethorphan 24.2 Antitussives
Diabetes Introduction
diabetes insipidus 26.3 Antidiuretic Hormones
diastolic blood pressure 18.1 Hypertension and Angina
Dietary Supplement and Health Education Act (DSHEA) 5.4 Vitamins, Minerals, and Complementary and Alternative Therapies
Differin 40.2 Acne Drugs
Dimensional analysis 2.4 Dosage Calculations
Diphenoxylate with atropine 30.2 Antidiarrheals
Diphtheria, tetanus toxoid, and acellular pertussis vaccine 6.2 Vaccine-Preventable Diseases, Vaccines, and Immunizations
direct observed therapy 15.2 Opioid Use Disorder Drugs
Direct-acting cholinergic agonists 10.2 Cholinergic Drugs
Direct-acting oral anticoagulants (DOACs) 20.2 Anticoagulants
Disease-modifying antirheumatic drugs (DMARDs) 6.4 Introduction to the Inflammatory Response and Anti-inflammatory Drugs
diuretic drugs 5.1 Fluid Volume
Diuretic resistance 34.1 Introduction to Diuretics
Diuretic therapy Introduction
DOAC Reversal Agents 20.2 Anticoagulants
Donepezil transdermal 10.4 Alzheimer’s Drugs
Dopamine antagonists 11.2 Anti-Parkinsonian Drugs
Dorzolamide 2% solution 38.4 Antiglaucoma Drugs
Dosage calculations 2.4 Dosage Calculations
Doxycin 40.2 Acne Drugs
Doxycycline hyclate 40.2 Acne Drugs
Dronabinol 30.1 Antiemetics
drug administration Introduction
drug calculation 2.4 Dosage Calculations
Drug Supply Chain Security Act 1.2 Drug Sources, Forms, and Names
Dry macular degeneration (DMD) 38.1 Introduction to the Eyes
E
eating disorder 32.2 Anorexiants
echothiopate 10.2 Cholinergic Drugs
ejection fraction 19.1 Heart Failure
Electrocardiography (EKG or ECG) 16.3 Conduction of Electrical Impulses
Electroencephalogram (EEG) 12.1 Epilepsy and Anticonvulsant Drugs
electrolyte balance 4.1 What Is Homeostasis?
Electrolytes 5.2 Electrolytes
electronic medication administration record 3.3 Documentation and Informatics
end-stage renal disease (ESRD) 34.1 Introduction to Diuretics
Endocrine glands Introduction
endocrine system Introduction
Eptifibatide 20.3 Antiplatelets
erythema multiforme 35.1 Urinary Anti-infectives
Erythrocytopenia 8.2 Chemotherapeutic Drugs
Erythropoietin production 33.1 Introduction to the Renal System
Escitalopram 13.1 Antidepressants
Essential fatty acids (EFAs) 32.1 Introduction to Weight Management
Estradiol cypionate 37.2 Feminizing Hormonal Therapy
exfoliative dermatitis 35.1 Urinary Anti-infectives
external auditory canal 39.1 Introduction to the Ears
External ocular structures 38.1 Introduction to the Eyes
extrapyramidal symptoms 13.2 Antipsychotics, 30.1 Antiemetics
F
fasting blood glucose 28.1 Introduction to Diabetes
Febrile neutropenia 8.2 Chemotherapeutic Drugs
feedback loop 4.1 What Is Homeostasis?
female-to-male (FTM) transition 37.3 Masculinizing Hormonal Therapy
fenestrated capillaries 33.1 Introduction to the Renal System
Finacea 40.2 Acne Drugs
Finevin 40.2 Acne Drugs
First-generation antipsychotics 13.2 Antipsychotics, 15.3 Alcohol Use Disorder Drugs
First-generation short-acting sulfonylureas 28.3 Oral Antidiabetic Drugs
Flovent HFA 25.2 Corticosteroids
fluid balance 4.1 What Is Homeostasis?
fluid imbalance 5.1 Fluid Volume
Fluid volume 5.1 Fluid Volume
Fluid volume deficit 5.1 Fluid Volume
Fluid volume excess 5.1 Fluid Volume
Fluid volume replacement 5.1 Fluid Volume
Fluphenazine 13.2 Antipsychotics
Fluticasone 25.2 Corticosteroids
Folate Antimetabolites 8.2 Chemotherapeutic Drugs
Food and Drug Administration (FDA) 1.2 Drug Sources, Forms, and Names
full mu opioid receptor agonist 15.2 Opioid Use Disorder Drugs
Fulvestrant 8.3 Hormonal Therapy
G
Gamma-Aminobutyric Acid Structural Analogs 11.4 Drugs Used in the Treatment of Multiple Sclerosis
gastroesophageal reflux disease (GERD) 29.2 Introduction to the Esophagus and Stomach, Introduction
gastrointestinal (GI) system Introduction
gender and racial bias 18.1 Hypertension and Angina
gestational diabetes 28.1 Introduction to Diabetes
Glomerular capillary hydrostatic pressure 33.1 Introduction to the Renal System
Glomerular capillary oncotic pressure 33.1 Introduction to the Renal System
Glyburide/metformin 28.3 Oral Antidiabetic Drugs
glycolysis 5.2 Electrolytes
glycosylated hemoglobin (A1c) 28.1 Introduction to Diabetes
gonadotropin-releasing hormone (GnRH) 36.1 Review of the Female Reproductive System
grades of hypertension 18.1 Hypertension and Angina
Granisetron 30.1 Antiemetics
granulocytopenia 8.2 Chemotherapeutic Drugs
growth hormone receptor antagonists 26.2 Growth Hormones and Suppressants
growth hormone suppressants 26.2 Growth Hormones and Suppressants
H
Health Information Technology for Economic and Clinical Health (HITECH) Act 3.1 Legal Considerations
Health Insurance Portability and Accountability Act 3.1 Legal Considerations
Healthy People 2030 Introduction
Heart failure 19.1 Heart Failure
heart failure with preserved ejection fraction (HFpEF) 19.1 Heart Failure
heart failure with reduced ejection fraction (HFrEF) 19.1 Heart Failure
hemoglobin Introduction
hemorrhagic cystitis 8.2 Chemotherapeutic Drugs
Heparin-induced thrombocytopenia (HIT) 20.2 Anticoagulants
hepatotoxicity 14.2 Nonopioid Analgesics
High-density lipoproteins (HDL or HDL-cholesterol) 21.1 Introduction to Lipoprotein and Apolipoproteins
Histamine type-2 receptor antagonists 29.3 Introduction to the Small and Large Intestines
histamine-1 receptor antagonist 13.2 Antipsychotics
homeostatic mechanism 4.3 Maintaining Homeostasis
homeostatic response system 4.4 Negative Feedback Loop
hormonal therapy 8.3 Hormonal Therapy
household system 2.4 Dosage Calculations
Human chorionic gonadotropin (hCG) 36.2 Hormonal, Contraception, and Infertility Drugs